SCHEMBL4595010

SCHEMBL4595010

CCCCc1ncco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL859772 0.94 FAAH (0.40)
SCHEMBL15201267 0.92 FAAH (0.42)
SCHEMBL11510236 0.92 FAAH (0.42)
SCHEMBL7431163 0.92 FAAH (0.42)
SCHEMBL10577731 0.92 FAAH (0.42)
SCHEMBL543465 0.92 FAAH (0.42)
SCHEMBL18649069 0.92 FAAH (0.42)
Fluoride SCHEMBL28689077 0.92 FAAH (0.39)
Bromide SCHEMBL29849486 0.90 FAAH (0.41)
SCHEMBL6012846 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3080105-A1 SUBSTITUTED DIALKYL(OXIDO)-LAMBDA4-SULFANYLIDENE NICOTINAMIDE DERIVATIVES AS KINASE INHIBITORS ALLERGAN, INC. (US) 2016-10-19 EP claimed
WO-2015089210-A1 SUBSTITUTED DIALKYL(OXIDO)-Λ4-SULFANYLIDENE NICOTINAMIDE DERIVATIVES AS KINASE INHIBITORS ALLERGAN, INC. (US) 2015-06-18 WO claimed
CN-101747597-A Conductive master batch and conductive single fiber TAIWAN TEXTILE RES INST 2010-06-23 CN claimed
WO-2008105607-A1 HETEROARYL-IMIDAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS GREEN CROSS CORPORATION (KR) 2008-09-04 WO claimed
US-7163933-B2 Treating agent for Paget's disease of bone TEIJIN LIMITED (JP) 2007-01-16 US claimed
US-20030191094-A1 Treating agent for Paget's disease of bone TEIJIN LIMITED 2003-10-09 US claimed
EP-1342796-A2 Compound for the treatment of paget's disease of bone TEIJIN LIMITED (JP) 2003-09-10 EP claimed
JP-2002524392-A 2002-08-06 JP claimed
EP-1100802-A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF 3M Innovative Properties Company (US) 2001-05-23 EP claimed
WO-2000006577-A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2000-02-10 WO claimed
CN-115784815-B Butyloxapol flame retardant material and preparation method and application thereof 北京理工大学 2024-01-30 CN disclosed
CN-115784815-B Butyloxapol flame retardant material and preparation method and application thereof 北京理工大学 2024-01-30 CN disclosed
CN-116621119-A Surface coating modified AlH 3 Processing method and application thereof 湖北航天化学技术研究所 2023-08-22 CN disclosed
CN-112595630-B Device and method for testing leveling property of solid propellant slurry 上海航天化工应用研究所 2023-05-09 CN disclosed
EP-4126852-A1 AZASPIROCYCLES AS MONOACYLGLYCEROL LIPASE MODULATORS Janssen Pharmaceutica NV (BE) 2023-02-08 EP disclosed
EP-1340780-A1 METAL CATALYST FOR RING-OPENING POLYMERIZATION OF HETEROCYCLIC COMPOUND SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-03 EP disclosed
EP-1240153-A1 AMINOTHIAZOLE INHIBITORS OF CYCLIN DEPENDENT KINASES Bristol-Myers Squibb Company (US) 2002-09-18 EP disclosed
WO-2001044217-A1 AMINOTHIAZOLE INHIBITORS OF CYCLIN DEPENDENT KINASES BRISTOL-MYERS SQUIBB CO. (US) 2001-06-21 WO disclosed
CN-1023227-C Prepn. of 2,5-dibenzoxazolyl thiophene WUHAN CHEMICAL INDUSTRY INST (CN) 1993-12-22 CN disclosed
EP-0104157-B1 RUBBER COMPOSITIONS CONTAINING A VULCANIZATION SYSTEM ALTERATIVE Monsanto Company (US) 1986-04-02 EP disclosed